ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$499,000
-88.7%
137,389
-89.1%
0.00%
-83.3%
Q4 2020$4,412,000
+9.4%
1,260,555
-25.0%
0.01%0.0%
Q3 2020$4,034,000
+99.4%
1,680,822
+52.1%
0.01%
+50.0%
Q2 2020$2,023,0001,105,2480.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders